<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The proto-oncogene, pleomorphic <z:mpath ids='MPATH_270'>adenoma</z:mpath> gene-like 2 (PLAGL2), is implicated in a variety of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> including <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), malignant <z:hpo ids='HP_0009733'>glioma</z:hpo>, <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, and <z:mp ids='MP_0002027'>lung adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>There is additional evidence that PLAGL2 can function as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor by initiating cell cycle arrest and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Interestingly, PLAGL2 has also been implicated in human <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, a disease that is characterized by ineffective hematopoiesis and can lead to fatal cytopenias (low blood counts) as a result of <z:mp ids='MP_0006042'>increased apoptosis</z:mp> in the marrow, or, in about one-third of cases, can progress to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>To gain a better understanding of the actions of PLAGL2 in human myeloid cells, we generated a stable PLAGL2-inducible cell line, using human promonocytic U937 cells </plain></SENT>
<SENT sid="4" pm="."><plain>PLAGL2 expression inhibited cell proliferation which correlated with an accumulation of cells in G1, apoptotic DNA-laddering, an increase in caspase 3, 8, and 9 activity, and a loss of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> transmembrane potential </plain></SENT>
<SENT sid="5" pm="."><plain>There was significant increase in the p53 homologue, p73, with PLAGL2 expression, and consistent with mechanisms of p73-regulated cell cycle control and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, there was increased expression of known p73 target genes p21, DR5, TRAIL, and Bax </plain></SENT>
<SENT sid="6" pm="."><plain>PLAGL2-induced cell cycle block was abolished in the presence of p73 siRNA </plain></SENT>
<SENT sid="7" pm="."><plain>Together, these data support a role for PLAGL2 in cell cycle regulation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> via activation of p73 </plain></SENT>
</text></document>